Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0PEI
|
||||
| Drug Name |
(S)-3,3-dimethyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate
|
||||
| Synonyms |
CHEMBL191588
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C30H38N4O5
|
||||
| Canonical SMILES |
CCCC[C@H](NC(=O)O[C@@H](Cc1oc(nn1)c2ccccc2)C(C)(C)C)C(=O)C(=O)N[C@H](C)c3ccccc3
|
||||
| InChI |
InChI=1S/C30H38N4O5/c1-6-7-18-23(26(35)27(36)31-20(2)21-14-10-8-11-15-21)32-29(37)38-24(30(3,4)5)19-25-33-34-28(39-25)22-16-12-9-13-17-22/h8-17,20,23-24H,6-7,18-19H2,1-5H3,(H,31,36)(H,32,37)/t20-,23+,24+/m1/s1
|
||||
| InChIKey |
OOESIBLDEWSAMK-QDSKXPNFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.